logo-large
  • Browse Categories

Publications by authors named "Junpei Okamura"

Claim this Profile
E
Evolution of Hepatocellular Carcinoma Treatment Outcomes Over Two Decades in Japan: Improvements in Early-Stage Viral Disease.
Kazuya Kariyama, Kazuhiro Nouso, Atsushi Hiraoka, Fujimasa Tada, Hideko Ohama, Junpei Okamura

Hepatol Res· November 2025


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sofosbuvir plus ribavirin is tolerable and effective even in elderly patients 75-years-old and over.
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima, Junpei Okamura

World J Hepatol· September 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combination with portosystemic shunt occlusion and antiviral therapy improves prognosis of decompensated cirrhosis.
Hideyuki Tamai, Hiroki Minamiguchi, Yoshiyuki Ida, Naoki Shingaki, Tokuro Muroki, Junpei Okamura

JGH Open· August 2020


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-world safety and efficacy of sofosbuvir and ledipasvir for elderly patients.
Hideyuki Tamai, Naoki Shingaki, Yoshiyuki Ida, Ryo Shimizu, Shuya Maeshima, Junpei Okamura

JGH Open· December 2018


Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
© PubHawk
  • About PubHawk
  • Privacy Policy
  • Sitemap
Socials: